Dr Agarwals Eye Hospital Share Price

207.05

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 12-May-2020 - -
DR.AGARWALS EYE HOSPITAL LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2020 ,inter alia, to consider and approve Audited Financial results of the Company for the Quarter and year ended 31st March, 2020 and to consider recommendation of dividend, if any, for the year ended 31st March, 2020. Final Dividend & Audited Results (As Per BSE Bulletin Dated on 12-05-2020) Approved and have taken on record the Audited Financial Results for the quarter and financial year ended 31st March, 2020. In this regard please find enclosed copies of the following i. Statement showing the Audited Financial results for the quarter and financial year ended 31st March, 2020. ii. Auditors report forming part of the Financial Statement iii. Declaration in respect of the Auditors Report with unmodified opinion 2. Recommended the appointment of M/s.Deloitte Haskins & Sells, Chartered Accountants (FRN - 008072S), as the Statutory Auditors of the Company for the second term of five years to hold office from the conclusion of the twenty sixth Annual General Meeting until the thirty first Annual General Meeting of the Company with respect to the financial year beginning 1st April 2020 and ending 31st March 2025. In terms of SEBI Circular CIR/CFD/CMD/4/2015 dated 9th September 2015 a brief profile of M/s.Deloitte Haskins & Sells, Chartered Accountants is enclosed. (As Per BSE Announcement Dated on 19.05.2020)
Board Meeting - 14-Jan-2020 - -
DR.AGARWALS EYE HOSPITAL LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2020 ,inter alia, to consider and approve The Board of Directors of the Company is scheduled to be held on the Tuesday, 28th January, 2020 at the Registered office of the Company, inter-alia to consider and approve the Unaudited Financial Results of the Company for the Quarter and period ended 31st December, 2019 Appointment of Secretarial Auditor for the financial year 2019-20 (As Per BSE Announcement dated on 29/01/2020)
Board Meeting - 19-Oct-2019 - -
DR.AGARWALS EYE HOSPITAL LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2019 ,inter alia, to consider and approve Inter-alia to consider and approve the Unaudited Financial Results of the Company for the Quarter and half year ended 30th September, 2019. Un-audited Financial Results for the quarter and half year ended 30th September, 2019 Outcome of the Board meeting held on October 25, 2019. (As Per BSE Announcement Dated 25.10.2019)
Board Meeting - 29-Jul-2019 - -
DR.AGARWALS EYE HOSPITAL LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2019 ,inter alia, to consider and approve Ref: Script Code 526783 We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on the Monday, 5th August, 2019 at the Registered office of the Company, inter-alia to consider and approve the Unaudited Financial Results of the Company for the Quarter ended 30th June, 2019. Copy of notice of the board meeting required to be published in the Newspaper as per the Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is enclosed. This Notice is being given pursuant to Regulation 29 and other applicable Regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your information and further dissemination. Kindly acknowledge the receipt.
Board Meeting - 03-Jun-2019 - -
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 1. Appointment of Ms. Jully Jivani as Company Secretary & Compliance Officer of the Company In view of the vacancy arising in the position of Company Secretary, and on the recommendation of the Nomination and Remuneration Committee, the Board of Directors have approved the appointment of Ms. Jully H Jivani as the Company Secretary and Compliance Officer of the Company w.e.f.3rd June, 2019. Brief profile of Ms. Jully Jivani is attached. 2.Appointment of Mrs. Lakshmmi Subramanian as Additional Director as an Independent Director Pursuant to the recommendation of the Nomination and Remuneration Committee, the Board of Directors have approved the appointment of Mrs. Lakshmmi Subramanian (DIN: 00001439) as an Additional Director under the category of Independent, with effect from 3rd June, 2019 until the ensuing Annual General Meeting. Brief profile of Mrs. Lakshmmi Subramanian is attached. Pursuant to the directions dated 14 June 2018 of SEBI to the stock exchanges and based on the declarations received, we hereby inform that Mrs. Lakshmmi Subramanian is not debarred from holding Office of Director by virtue of any order passed by SEBI or any other such authority and therefore, she is not disqualified to be appointed as a Director. Mrs. Lakshmmi Subramanian is not related to any of the existing Directors of the Company. 3. Appointment of Dr. Adil Agarwal as Additional Director and as a Non- Executive Director Pursuant to the recommendation of the Nomination and Remuneration Committee, the Board of Directors have approved the appointment of Dr. Adil Agarwal ( DIN: 01074272) as an Additional Director under the category of Non- Executive, with effect from 3rd June, 2019 until the ensuing Annual General Meeting. Brief profile of Dr. Adil Agarwal is attached. Pursuant to the directions dated 14 June 2018 of SEBI to the stock exchanges and based on the declarations received, we hereby inform that Dr. Adil Agarwal is not debarred from holding Office of Director by virtue of any order passed by SEBI or any other such authority and therefore, she is not disqualified to be appointed as a Director. Dr Adil Agarwal is not related to any of the existing Directors of the Company except Dr. Amar Agarwal - Chairman and Managing Director and Dr. Athiya Agarwal- Wholetime Director. The Board Meeting commenced at 3:00 P.M and concluded at 5:00 P.M Pursuant to Regulation 19(1) of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015- Nomination & Remuneration Committee 1. Reconstitution of Nomination & Remuneration Committee The Board in its meeting held on 3rd June, 2019 has reconstituted its Nomination & Remuneration Committee inducting Mrs. Lakshmmi Subramanian, Independent Director (DIN: 00001439) and Dr. Adil Agarwal, Non-Executive Director (DIN:01074272) as the Member of the Nomination & Remuneration Committee. The Reconstituted committee now comprises of the following: S.NO Name Designation 1 Mr. Sanjay Anand Chairman 2 Mrs. Lakshmmi Subramanian Member 3 Mr. T.R. Ramasubramanaian Member 4 Dr. Adil Agarwal Member The Board Meeting commenced at 3:00 P.M and concluded at 5:00 P.M (As Per BSE Announcement Dated on 04.06.2019)